Podoplanin Expression Correlates with Disease Progression in Mycosis Fungoides

The aim of this study was to investigate the role of lymphangiogenesis in the clinical progression and outcome of mycosis fungoides. Immunohistochemistry and Western blot techniques were used to assess the expression of podoplanin and vascular endothelial growth factor C in mycosis fungoides. Expression of vascular endothelial growth factor C measured by immunohistochemistry was significantly higher in mycosis fungoides samples in comparison with control cases (chronic benign dermatoses) (p？=？0.0012). Increased expression of podoplanin was found in advanced vs. early mycosis fungoides (p？<？0.0001), and was positively correlated with cutaneous and nodal involvement (p？<？0.001, p？<？0.0001; respectively). Higher podoplanin expression was also significantly associated with shorter survival (p？<？0.001). Strong positive correlation was observed between expression of podoplanin analysed by immunohistochemistry and Western blot (r？=？0.75, p？<？0.0001). A similar association was shown regarding expression of vascular endothelial growth factor C (r？=？0.68, p？=？0.0007). In conclusion, these results suggest that increased expression of podoplanin is associated with poor clinical course, as well as shorter survival, of patients with mycosis fungoides.